China innovative drug out-licensing deal value reaches new high in first half of 2026, says CCTV
SHANGHAI, July 13 (Reuters) - The value of China's innovative drug out-licensing deals reached about $110 billion between January and June, a record h...
Read the full articleYou might also wanna read
China innovative drug out-licensing deal value reaches new high in first half of 2026, says CCTV
SHANGHAI, July 13 (Reuters) - The value of China's innovative drug out-licensing deals reached about $110 billion between January and June,
China’s drug industry pivots to AI-powered candidates to drive next wave of deals
After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towa
China’s drug industry pivots to AI-powered candidates to drive next wave of deals
After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towa
Insilico + CMS $1.2B CNS AI Drug Deal Explained (July 2026)
Insilico Medicine and China Medical System expanded their AI drug discovery collaboration July 12, 2026 with ~1.2B RMB milestones. What it i
AstraZeneca pens $2.1B Sino deal for challenger to Merck’s COPD drug Ohtuvayre
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & Co.’s chronic ob
Streamlined and Sponsor-Friendly: What China’s Amended Drug Regulations Mean for Pharma Companies
On January 27, 2026, China’s State Council published the amended Implementing Regulations of the Drug Administration Law, which will take ef
Comments
Sign in to join the conversation.
No comments yet. Be the first.